GENENTA SCIENCE S.P.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.442 USD | -0.69% |
|
+4.31% | -30.46% |
| Apr. 08 | Genenta Science S.P.A. Announces Resignation of Board Members | CI |
| Mar. 29 | Genenta Science S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Genenta Science S.p.A.
a.oBGIzSEq4rhZH1WhNz5b1rZG2ZlM-SM_7tksz0qR9cg.lVi9klFPlOwpVibuXHE0jPIRitcIk2AK16tlogvnj6HPJMG8Fk6Q3XRpJg~9d5b385c3d9d8bdacea805442f14ab04
Upcoming events on Genenta Science S.p.A.
No events available
Past events on Genenta Science S.p.A.
| 2023-10-01 | Chardan Genetic Medicines Conference |
| 2023-09-25 | Cantor Global Healthcare Conference |
| 2023-09-22 | GSTC Scientific Meeting |
| 2023-09-10 | H.C. Wainwright Global Investment Conference |
| 2023-06-20 10:00 am | Maxim Group Virtual Healthcare Conference |
| 2023-06-13 | European Association for Cancer Research Congress |
| 2023-06-04 | BIO International Convention |
| 2023-05-31 | Macrophage Symposium |
| 2023-05-23 | ASTCT + EBMT Joint Basic and Translational Scientific Meeting |
| 2023-05-11 11:30 am | Sidoti Micro-Cap Virtual Conference |
| 2023-04-26 07:00 am | Q4 2022 Earnings Release |
| 2023-03-11 | Roth Conference |
| 2022-11-10 09:00 am | Society for Immunotherapy of Cancer Meeting |
| 2022-10-24 07:30 am | Interim 2022 Earnings Release |
| 2022-10-12 06:10 am | European Society of Gene & Cell Therapy Congress |
| 2022-10-06 10:15 am | Roth Inaugural Healthcare Opportunities Conference |
| 2022-10-03 04:30 am | Chardan Genetic Medicines Conference |
| 2022-09-15 10:40 am | Cantor Fitzgerald Cell & Gene Therapy Conference |
| 2022-09-13 09:00 am | H.C. Wainwright Global Investment Conference |
| 2022-06-10 10:30 am | European Hematology Association Meeting |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million EUR | Released Forecast Spread | 0,00 | 0,00 0,00 - | -11,0 -9,50 -16.19% | 0,00 0,00 - | 0,00 |
|
EBIT Million EUR | Released Forecast Spread | 0,00 | -5,69 -8,90 36.07% | -11,0 -8,78 -25.74% | -11,7 -13,7 14.58% | -15,1 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 | -5,53 -8,90 37.87% | -8,48 -6,44 -31.72% | -11,6 -13,7 15.22% | -15,1 |
|
Net income Million EUR | Released Forecast Spread | -5,59 | -5,53 -8,90 37.87% | -8,48 -6,44 -31.72% | -11,6 -13,7 15.22% | -15,1 |
|
EPS EUR | Released Forecast Spread | -0,38 | -0,37 -0,57 35.09% | -0,47 -0,35 -34.29% | -0,64 -0,75 14.67% | -0,73 |
| Announcement Date | 09/11/21 | 02/05/22 | 21/04/23 | 29/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 S1 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | |
|
EBITDA Million EUR | Released Forecast Spread | -4,15 -2,30 -80.49% | -6,89 -5,20 -32.43% | -6,78 -5,90 -14.9% | |||||
|
EBIT Million EUR | Released Forecast Spread | -1,65 -4,88 66.24% | -6,89 -4,30 -60.3% | -4,93 -6,94 28.88% | |||||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -1,48 -4,88 69.61% | -2,11 -2,30 8.16% | -6,37 -4,30 -48.08% | -6,76 -4,80 -40.82% | -4,89 -6,94 29.55% | |||
|
Net income Million EUR | Released Forecast Spread | -4,05 | -1,48 -4,88 69.61% | -2,11 -2,30 8.16% | -6,37 -4,30 -48.08% | -6,76 -4,80 -40.82% | -4,89 -6,94 29.55% | ||
|
EPS EUR | Released Forecast Spread | -0,27 | -0,10 -0,30 66.67% | -0,12 -0,15 20% | -0,35 -0,23 -52.17% | -0,37 -0,23 -60.87% | -0,27 -0,38 28.95% | ||
| Announcement Date | 24/11/21 | 02/05/22 | - | 25/10/22 | 25/10/22 | 21/04/23 | 20/10/23 | 29/03/24 |
More events
Past sector events for Genenta Science S.p.A.
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
| 2024-03-27 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q4 2023 Earnings Release |
| 2024-03-27 10:25 am | PHARMARON BEIJING CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GNTA Stock
- Calendar Genenta Science S.p.A.
